View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsMedMen Enterprises 배당 및 자사주 매입배당 기준 점검 0/6MedMen Enterprises 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공고 • Apr 28+ 1 more updateMedMen Enterprises Inc. Announces Resignation of DirectorsMedMen Enterprises Inc. announced that it made an assignment into bankruptcy pursuant to Canadas Bankruptcy and Insolvency Act (the Bankruptcy Proceedings) on April 24, 2024 and B. Riley Farber Inc. was appointed as the Company's bankruptcy trustee (in such capacity, the Bankruptcy Trustee). The each of the Company's directors resigned effective immediately prior to the commencement of the Bankruptcy Proceedings.공고 • Jan 25+ 1 more updateMedMen Enterprises Inc. Announces Management ChangesMedMen Enterprises Inc. announced that Ellen Deutsch Harrison has stepped down as board member effective January 19, 2024 and the board has appointed Richard Ormond as chief restructuring officer. Furthermore, Michael Serruya, executive chairman of the board, who has served on the Board since August 2021, has stepped down from the Board effective January 24, 2024.공고 • Nov 18MedMen Enterprises Inc. announced delayed 10-Q filingOn 11/17/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공고 • Jul 06+ 2 more updatesMedMen Enterprises Inc. Appoints Ellen Deutsch to Board of DirectorsMedMen Enterprises Inc. announced the appointment of Ellen Deutsch to the Company’s Board of Directors, increasing the size of the Board of Directors to six. Deutsch brings deep operational, marketing, and financial experience and expertise in the cannabis and CPG industries, having most recently served as Senior Vice President of Market Development and Shared Services at Acreage Holdings. Before joining Acreage, Deutsch served as Executive Vice President/Chief Operating Officer at Stem Holdings, Inc, following two decades in the C-suite of Hain Celestial as its Senior Vice President/Chief Growth Officer among other leadership roles.공고 • Jun 17MedMen Enterprises Inc. Announces CFO Changes, Effective June 29, 2023MedMen Enterprises Inc. announced the resignation of Ana Bowman as Chief Financial Officer, effective June 29, 2023. Bowman has served as CFO since 2022. MedMen has begun a formal search for a new CFO.공고 • May 06MedMen Enterprises Inc. announced delayed 10-Q filingOn 05/05/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공고 • Nov 24Medmen Enterprises Inc. Prevails in Lawsuit Against Former CFO James ParkerMedMen Enterprises Inc. announced the company has prevailed in a high-profile lawsuit brought by former CFO James Parker. In 2019, Parker filed suit against MedMen, alleging wrongful termination, breach of contract and retaliation, seeking in excess of $20,000,000.00 in damages. MedMen has always maintained that the lawsuit and claims were baseless and without merit. The jury agreed, ruling in favor of MedMen on all claims and determining MedMen does not owe Parker any damages. MedMen also asserted affirmative claims against Parker. The jury found that Parker breached his contract, his fiduciary duty, his duty of loyalty, misappropriated trade secrets, and committed conversion, but that there was no harm/damage resulting from his misconduct.공고 • Aug 19MedMen Enterprises Inc. announced that it expects to receive $100 million in funding from Serruya Private Equity Inc.MedMen Enterprises Inc. announced a private placement of 416,666,667 units at a price of $0.24 per unit for gross proceeds of $100,000,000 on August 17, 2021. Each unit will consist of one class B subordinated voting share and one quarter of one share purchase warrant. Each warrant will entitle the holder to purchase a common share at a price of $0.288 per share for a period of five years. The transaction will be led by Serruya Private Equity Inc and included participation from other investors. Pursuant to the transaction, Michael Serruya from Serruya Private Equity Inc. will join the company's board of directors.공고 • May 18MedMen Enterprises Inc. announced that it has received $10 million in fundingMedMen Enterprises Inc. (CNSX:MMEN) announced a non-brokered Private Placement of 31,250,000? units at a price of $0.32 per unit for gross proceeds of $10,000,000 on May 17, 2021. Each unit consists of one Class B subordinate voting share and one share purchase warrant. Each warrant permits the holder to purchase one Share for a period of three years from the date of issuance at an exercise price of $0.352 per share.공고 • May 13MedMen Enterprises Inc. announced delayed 10-Q filingOn 05/12/2021, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공고 • Mar 19MedMen Enterprises Inc. announced that it expects to receive CAD 8 million in fundingMedMen Enterprises Inc. (CNSX:MMEN) announced a non-brokered Private Placement of 20,000,000 units at a price of CAD 0.40 per unit for gross proceeds of CAD 8,000,000 on March 18, 2021. Each unit consists of one Class B subordinate voting share and one share purchase warrant. Each warrant permits the holder to purchase one Share for a period of three years from the date of issuance at an exercise price of CAD 0.50 per Share.공고 • Feb 11MedMen Enterprises Inc. announced delayed 10-Q filingOn 02/10/2021, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공고 • Feb 04MedMen Enterprises Inc. to Report Q2, 2021 Results on Feb 16, 2021MedMen Enterprises Inc. announced that they will report Q2, 2021 results on Feb 16, 2021공고 • Jan 05MedMen Relaunches MedMen RedMedMen announced the relaunch of its signature house brand, MedMen Red in all California and Nevada locations. The line, first introduced in November 2019, is the intersection of premium quality and value, providing customers with exceptional cannabis products at very compelling prices. Cultivated locally in each state through a meticulous growing process, which takes about 14 weeks from seed to sale, every product is carefully considered. Offering a full product suite, including flower ($38/3.5g, $65/7g), pre-rolls ($9/single, $38/7-pack), cartridges ($38/1g), disposable vapes ($25/0.3g), and edibles ($15/10-pack), the MedMen Red line curates high quality, accessible cannabis for all. Company's premium flower strains include White Runtz, a derivative of Leafly’s Strain of the Year 2020, as well as two strains, GMO Cookies and MAC, with over 30% cannabinoid content. The line of disposable vapes and cartridges include classic strains like Pineapple Express, Northern Lights and Maui Wowie, while succulent flavors of Dragon Fruit, Key Lime, Mango, Strawberry, and Pineapple comprise the gummy offering.공고 • Dec 30MedMen Enterprises Announces Board ChangesMedMen Enterprises reported that Tom Lynch has been elected as Chairman of the Board of Directors, effective immediately. Lynch currently serves as the interim Chief Executive Officer for MedMen and was elected to the Board of Directors in November. Ben Rose has resigned as Chairman of the Board of Directors and as a Board member.공고 • Dec 20+ 1 more updateMedmen Enterprises Inc. Announces Resignation of Benjamin Rose from the Board of DirectorsOn December 14, 2020, Benjamin Rose provided his resignation to the Board of Directors of MedMen Enterprises Inc., effective immediately.공고 • Dec 18MedMen Enterprises Inc. Announces Board ChangesMedMen Enterprises Inc. announced that Tom Lynch has been elected as Chairman of the Board of Directors, effective immediately. Lynch currently serves as the interim Chief Executive Officer for MedMen and was elected to the Board of Directors in November. Ben Rosehas resigned as Chairman of the Board of Directors and as a Board member.공고 • Dec 04Medmen Enterprises Inc. Names Tracy Mccourt to the New Role of Chief Revenue OfficerMedMen Enterprises Inc. named Tracy McCourt to the new role of Chief Revenue Officer. In this role, McCourt will report directly to the Chief Executive Officer and lead the omni-channel marketing strategy as well as the Company's buying, merchandising and business intelligence efforts. Most recently, McCourt led the strategy for the brand affinity team at Zappos, where she developed the brand marketing strategy to align business goals with merchandising strategy.공고 • Nov 25MedMen Enterprises Inc. to Report Q1, 2021 Results on Dec 07, 2020MedMen Enterprises Inc. announced that they will report Q1, 2021 results at 5:00 PM, Eastern Standard Time on Dec 07, 2020공고 • Nov 24MedMen Enterprises Inc. Announces Launch of Viola Within All California LocationsMedMen Enterprises Inc. announced the launch of Viola within all California locations. Founded in 2011 by NBA veteran and MedMen board member, Al Harrington, Viola is a premium cannabis company that focuses on increasing minority ownership, reinvesting in the community and creating opportunity through social equity. Launching with five potent strains; J1, Wedding Cake, Watermelon Zkittlez, Mother’s Milk and Mandarin OG – the offer spans the full spectrum from sativa to indica. The launch will also include Viola’s sativa Candy Haze pre-roll. See full descriptions, as promoted, below. Flower Descriptions: J1: J1 is an uplifting super sativa nothing short of a clear headed buzz. Enticing trichome encrusted buds, accompanied by a tantalizing sweet aroma known to leave user feeling unstoppable!; Wedding Cake: This delectable strain offers euphoric effects with its peppery and earthy flavor profile. Novice smokers beware this indica dominant hybrid may knock sweet tooth out; Watermelon Zkittlez: Large dense nugs with a flavor profile reminiscent of favorite fruit candy, Watermelon Zkittlez is the perfect midnight snack to fulfill sweet tooth cravings. This scrumptious combo may ease to an elevated state of relaxation; Mandarin OG: Boasting a unique flavor profile of skunky, spicy, pine-like and orange flavors this powerhouse strain is known to combine a heavy body high with extreme mental relaxation. The perfect strain to unwind with after a long day; Mother's Milk: Luscious trichome encrusted dense nugs coupled with an earthy flavor profile may allow for a functional dreamy high. This sativa dominant hybrid is perfect for an evening out or a day relaxing in; Sativa Pre-Roll Description; and Candy Haze: Bred from Candyland and Haze, Candy Haze stays true to its origins supplying uplifting and stimulating effects. The perfect day time smoke or mood boosting high to get creative juices flowing.공고 • Sep 25MedMen Enterprises Inc. to Report Q4, 2020 Results on Oct 15, 2020MedMen Enterprises Inc. announced that they will report Q4, 2020 results on Oct 15, 2020공고 • Sep 17MedMen Enterprises Inc. announced that it expects to receive $10 million in fundingMedMen Enterprises Inc. (CNSX:MMEN) announced that a private placement of unsecured convertible debenture facility for gross proceeds of $10,000,000 on September 16, 2020. The company will issue the convertible debentures in the transaction. The transaction included participation from from existing lenders and institutional investors. On the same date, the company closed initial tranche of $1,000,000 and issued investors a total of 3,293,413 warrants, each exercisable at $0.21 per share for a period of 24 months from the date of issuance. The subsequent tranches expected to be closed in the coming months, subject to certain conditions. The convertible debentures shall have a conversion price equal to the closing price on the trading day immediately prior to the closing date, a maturity date of 24 months from the date of issuance and will bear interest from the date of issuance at 7.5% per annum, payable semi-annually in cash. The debentures issued to the investors for the initial tranche have a conversion price of $0.1670 per Class B Subordinate Voting Share. Subject to certain conditions, the company has the right to call additional tranches, totaling $1,000,000 each, no later than 20 trading days following the issuance of each tranche, including the initial tranche, up to a maximum of $10,000,000 under all tranches. The investors have the right to at least four additional tranches, with any such subsequent tranche to be at least $1,000,000. The debentures shall provide for the automatic conversion into shares in the event that the shares trade at a volume weighted average trading price that is 50% above the conversion price on the Canadian Securities Exchange for 45 consecutive trading days.공고 • Aug 25+ 1 more updateMedMen Enterprises Inc. (CNSX:MMEN) agreed to acquire all of the Assets of LVMC, LLC for $10.1 million.MedMen Enterprises Inc. (CNSX:MMEN) agreed to acquire all of the Assets of LVMC, LLC for $10.1 million on October 9, 2018. MedMen Enterprises Inc. (CNSX:MMEN) completed the acquisition of all of the Assets of LVMC, LLC on October 9, 2018.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 MMNF.Q 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: MMNF.Q 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장MedMen Enterprises 배당 수익률 vs 시장MMNF.Q의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (MMNF.Q)n/a시장 하위 25% (US)1.3%시장 상위 25% (US)4.1%업계 평균 (Pharmaceuticals)1.9%분석가 예측 (MMNF.Q) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 MMNF.Q 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 MMNF.Q 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 MMNF.Q 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: MMNF.Q 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/04/03 15:48종가2026/04/01 00:00수익2023/03/25연간 수익2022/06/25데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스MedMen Enterprises Inc.는 9명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관David McFadgenATB Cormark Historical (Cormark Securities)Matt BottomleyCanaccord GenuityPablo ZuanicCantor Fitzgerald & Co.6명의 분석가 더 보기
공고 • Apr 28+ 1 more updateMedMen Enterprises Inc. Announces Resignation of DirectorsMedMen Enterprises Inc. announced that it made an assignment into bankruptcy pursuant to Canadas Bankruptcy and Insolvency Act (the Bankruptcy Proceedings) on April 24, 2024 and B. Riley Farber Inc. was appointed as the Company's bankruptcy trustee (in such capacity, the Bankruptcy Trustee). The each of the Company's directors resigned effective immediately prior to the commencement of the Bankruptcy Proceedings.
공고 • Jan 25+ 1 more updateMedMen Enterprises Inc. Announces Management ChangesMedMen Enterprises Inc. announced that Ellen Deutsch Harrison has stepped down as board member effective January 19, 2024 and the board has appointed Richard Ormond as chief restructuring officer. Furthermore, Michael Serruya, executive chairman of the board, who has served on the Board since August 2021, has stepped down from the Board effective January 24, 2024.
공고 • Nov 18MedMen Enterprises Inc. announced delayed 10-Q filingOn 11/17/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공고 • Jul 06+ 2 more updatesMedMen Enterprises Inc. Appoints Ellen Deutsch to Board of DirectorsMedMen Enterprises Inc. announced the appointment of Ellen Deutsch to the Company’s Board of Directors, increasing the size of the Board of Directors to six. Deutsch brings deep operational, marketing, and financial experience and expertise in the cannabis and CPG industries, having most recently served as Senior Vice President of Market Development and Shared Services at Acreage Holdings. Before joining Acreage, Deutsch served as Executive Vice President/Chief Operating Officer at Stem Holdings, Inc, following two decades in the C-suite of Hain Celestial as its Senior Vice President/Chief Growth Officer among other leadership roles.
공고 • Jun 17MedMen Enterprises Inc. Announces CFO Changes, Effective June 29, 2023MedMen Enterprises Inc. announced the resignation of Ana Bowman as Chief Financial Officer, effective June 29, 2023. Bowman has served as CFO since 2022. MedMen has begun a formal search for a new CFO.
공고 • May 06MedMen Enterprises Inc. announced delayed 10-Q filingOn 05/05/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공고 • Nov 24Medmen Enterprises Inc. Prevails in Lawsuit Against Former CFO James ParkerMedMen Enterprises Inc. announced the company has prevailed in a high-profile lawsuit brought by former CFO James Parker. In 2019, Parker filed suit against MedMen, alleging wrongful termination, breach of contract and retaliation, seeking in excess of $20,000,000.00 in damages. MedMen has always maintained that the lawsuit and claims were baseless and without merit. The jury agreed, ruling in favor of MedMen on all claims and determining MedMen does not owe Parker any damages. MedMen also asserted affirmative claims against Parker. The jury found that Parker breached his contract, his fiduciary duty, his duty of loyalty, misappropriated trade secrets, and committed conversion, but that there was no harm/damage resulting from his misconduct.
공고 • Aug 19MedMen Enterprises Inc. announced that it expects to receive $100 million in funding from Serruya Private Equity Inc.MedMen Enterprises Inc. announced a private placement of 416,666,667 units at a price of $0.24 per unit for gross proceeds of $100,000,000 on August 17, 2021. Each unit will consist of one class B subordinated voting share and one quarter of one share purchase warrant. Each warrant will entitle the holder to purchase a common share at a price of $0.288 per share for a period of five years. The transaction will be led by Serruya Private Equity Inc and included participation from other investors. Pursuant to the transaction, Michael Serruya from Serruya Private Equity Inc. will join the company's board of directors.
공고 • May 18MedMen Enterprises Inc. announced that it has received $10 million in fundingMedMen Enterprises Inc. (CNSX:MMEN) announced a non-brokered Private Placement of 31,250,000? units at a price of $0.32 per unit for gross proceeds of $10,000,000 on May 17, 2021. Each unit consists of one Class B subordinate voting share and one share purchase warrant. Each warrant permits the holder to purchase one Share for a period of three years from the date of issuance at an exercise price of $0.352 per share.
공고 • May 13MedMen Enterprises Inc. announced delayed 10-Q filingOn 05/12/2021, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공고 • Mar 19MedMen Enterprises Inc. announced that it expects to receive CAD 8 million in fundingMedMen Enterprises Inc. (CNSX:MMEN) announced a non-brokered Private Placement of 20,000,000 units at a price of CAD 0.40 per unit for gross proceeds of CAD 8,000,000 on March 18, 2021. Each unit consists of one Class B subordinate voting share and one share purchase warrant. Each warrant permits the holder to purchase one Share for a period of three years from the date of issuance at an exercise price of CAD 0.50 per Share.
공고 • Feb 11MedMen Enterprises Inc. announced delayed 10-Q filingOn 02/10/2021, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공고 • Feb 04MedMen Enterprises Inc. to Report Q2, 2021 Results on Feb 16, 2021MedMen Enterprises Inc. announced that they will report Q2, 2021 results on Feb 16, 2021
공고 • Jan 05MedMen Relaunches MedMen RedMedMen announced the relaunch of its signature house brand, MedMen Red in all California and Nevada locations. The line, first introduced in November 2019, is the intersection of premium quality and value, providing customers with exceptional cannabis products at very compelling prices. Cultivated locally in each state through a meticulous growing process, which takes about 14 weeks from seed to sale, every product is carefully considered. Offering a full product suite, including flower ($38/3.5g, $65/7g), pre-rolls ($9/single, $38/7-pack), cartridges ($38/1g), disposable vapes ($25/0.3g), and edibles ($15/10-pack), the MedMen Red line curates high quality, accessible cannabis for all. Company's premium flower strains include White Runtz, a derivative of Leafly’s Strain of the Year 2020, as well as two strains, GMO Cookies and MAC, with over 30% cannabinoid content. The line of disposable vapes and cartridges include classic strains like Pineapple Express, Northern Lights and Maui Wowie, while succulent flavors of Dragon Fruit, Key Lime, Mango, Strawberry, and Pineapple comprise the gummy offering.
공고 • Dec 30MedMen Enterprises Announces Board ChangesMedMen Enterprises reported that Tom Lynch has been elected as Chairman of the Board of Directors, effective immediately. Lynch currently serves as the interim Chief Executive Officer for MedMen and was elected to the Board of Directors in November. Ben Rose has resigned as Chairman of the Board of Directors and as a Board member.
공고 • Dec 20+ 1 more updateMedmen Enterprises Inc. Announces Resignation of Benjamin Rose from the Board of DirectorsOn December 14, 2020, Benjamin Rose provided his resignation to the Board of Directors of MedMen Enterprises Inc., effective immediately.
공고 • Dec 18MedMen Enterprises Inc. Announces Board ChangesMedMen Enterprises Inc. announced that Tom Lynch has been elected as Chairman of the Board of Directors, effective immediately. Lynch currently serves as the interim Chief Executive Officer for MedMen and was elected to the Board of Directors in November. Ben Rosehas resigned as Chairman of the Board of Directors and as a Board member.
공고 • Dec 04Medmen Enterprises Inc. Names Tracy Mccourt to the New Role of Chief Revenue OfficerMedMen Enterprises Inc. named Tracy McCourt to the new role of Chief Revenue Officer. In this role, McCourt will report directly to the Chief Executive Officer and lead the omni-channel marketing strategy as well as the Company's buying, merchandising and business intelligence efforts. Most recently, McCourt led the strategy for the brand affinity team at Zappos, where she developed the brand marketing strategy to align business goals with merchandising strategy.
공고 • Nov 25MedMen Enterprises Inc. to Report Q1, 2021 Results on Dec 07, 2020MedMen Enterprises Inc. announced that they will report Q1, 2021 results at 5:00 PM, Eastern Standard Time on Dec 07, 2020
공고 • Nov 24MedMen Enterprises Inc. Announces Launch of Viola Within All California LocationsMedMen Enterprises Inc. announced the launch of Viola within all California locations. Founded in 2011 by NBA veteran and MedMen board member, Al Harrington, Viola is a premium cannabis company that focuses on increasing minority ownership, reinvesting in the community and creating opportunity through social equity. Launching with five potent strains; J1, Wedding Cake, Watermelon Zkittlez, Mother’s Milk and Mandarin OG – the offer spans the full spectrum from sativa to indica. The launch will also include Viola’s sativa Candy Haze pre-roll. See full descriptions, as promoted, below. Flower Descriptions: J1: J1 is an uplifting super sativa nothing short of a clear headed buzz. Enticing trichome encrusted buds, accompanied by a tantalizing sweet aroma known to leave user feeling unstoppable!; Wedding Cake: This delectable strain offers euphoric effects with its peppery and earthy flavor profile. Novice smokers beware this indica dominant hybrid may knock sweet tooth out; Watermelon Zkittlez: Large dense nugs with a flavor profile reminiscent of favorite fruit candy, Watermelon Zkittlez is the perfect midnight snack to fulfill sweet tooth cravings. This scrumptious combo may ease to an elevated state of relaxation; Mandarin OG: Boasting a unique flavor profile of skunky, spicy, pine-like and orange flavors this powerhouse strain is known to combine a heavy body high with extreme mental relaxation. The perfect strain to unwind with after a long day; Mother's Milk: Luscious trichome encrusted dense nugs coupled with an earthy flavor profile may allow for a functional dreamy high. This sativa dominant hybrid is perfect for an evening out or a day relaxing in; Sativa Pre-Roll Description; and Candy Haze: Bred from Candyland and Haze, Candy Haze stays true to its origins supplying uplifting and stimulating effects. The perfect day time smoke or mood boosting high to get creative juices flowing.
공고 • Sep 25MedMen Enterprises Inc. to Report Q4, 2020 Results on Oct 15, 2020MedMen Enterprises Inc. announced that they will report Q4, 2020 results on Oct 15, 2020
공고 • Sep 17MedMen Enterprises Inc. announced that it expects to receive $10 million in fundingMedMen Enterprises Inc. (CNSX:MMEN) announced that a private placement of unsecured convertible debenture facility for gross proceeds of $10,000,000 on September 16, 2020. The company will issue the convertible debentures in the transaction. The transaction included participation from from existing lenders and institutional investors. On the same date, the company closed initial tranche of $1,000,000 and issued investors a total of 3,293,413 warrants, each exercisable at $0.21 per share for a period of 24 months from the date of issuance. The subsequent tranches expected to be closed in the coming months, subject to certain conditions. The convertible debentures shall have a conversion price equal to the closing price on the trading day immediately prior to the closing date, a maturity date of 24 months from the date of issuance and will bear interest from the date of issuance at 7.5% per annum, payable semi-annually in cash. The debentures issued to the investors for the initial tranche have a conversion price of $0.1670 per Class B Subordinate Voting Share. Subject to certain conditions, the company has the right to call additional tranches, totaling $1,000,000 each, no later than 20 trading days following the issuance of each tranche, including the initial tranche, up to a maximum of $10,000,000 under all tranches. The investors have the right to at least four additional tranches, with any such subsequent tranche to be at least $1,000,000. The debentures shall provide for the automatic conversion into shares in the event that the shares trade at a volume weighted average trading price that is 50% above the conversion price on the Canadian Securities Exchange for 45 consecutive trading days.
공고 • Aug 25+ 1 more updateMedMen Enterprises Inc. (CNSX:MMEN) agreed to acquire all of the Assets of LVMC, LLC for $10.1 million.MedMen Enterprises Inc. (CNSX:MMEN) agreed to acquire all of the Assets of LVMC, LLC for $10.1 million on October 9, 2018. MedMen Enterprises Inc. (CNSX:MMEN) completed the acquisition of all of the Assets of LVMC, LLC on October 9, 2018.